Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus: An Update

Author： Marcel M.C. Hovens   Jouke T. Tamsma   Edith D. Beishuizen   Menno V. Huisman  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.4, 2005-01, pp. : 433-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

A diet high in low-fat dairy products may reduce the risk of developing type 2 diabetes mellitus in men

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Management of Type 2 Diabetes Mellitus and Cardiovascular Risk: Lessons from Intervention Trials

By Yki-Järvinen H.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 975-983

Adis International

Access to resources Recommend Favorite

Fluoroquinolones reduce CHD risk in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2281-2296

Informa Healthcare

Access to resources Recommend Favorite